Clinical Trial Update: Cardio-cerebrovascular Disease and Aspirin Ulcer Relapse Evaluation [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating aspirin-related ulcer relapse in cardio-cerebrovascular disease. The study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardio-cerebrovascular Disease

Drugs mentioned

• Aspirin (Aspirin)

Snippet

Sponsor: Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan | Conditions: Cardio-cerebrovascular Disease | Phase 3 | Status: COMPLETED